Helmy Eltoukhy and AmirAli Talasaz, Guardant’s co-CEOs, discussed the company’s upcoming milestones, how they plan to separate themselves from the competition, and the future of liquid biopsies. […]
“The idea of reversing disease is not part of the lexicon of physicians, because the idea of reversing disease is tantamount to reversing time.” […]
Ionis Pharmaceuticals — which blazed a trail in RNA-targeted medicines — is jumping into gene editing with a new partnership with Metagenomi. […]
Copyright © 2022 Biotech Networks, LLC
